Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma

Chest

Volumn 134, Issue 4, 2008, Pages 733-739

  Malerba, Mario ^a   Ragnoli, Beatrice ^a   Radaeli, Alessandro ^a   Tantucci, Claudio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Asthma treatment; Exhaled nitric oxide; Induced sputum; Markers of airway inflammation

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHACHOLINE; NITRIC OXIDE; SALBUTAMOL; SODIUM CHLORIDE;

ADULT; AIRWAY; ANALYZER; ARTICLE; ASTHMA; CHEMOLUMINESCENCE; CLINICAL ARTICLE; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG FUNCTION TEST; MALE; METERED DOSE INHALER; NEBULIZER; PRIORITY JOURNAL; PROVOCATION TEST; RECOMMENDED DRUG DOSE; SCORING SYSTEM; SPUTUM; SPUTUM ANALYSIS; SYMPTOM; TREATMENT OUTCOME;

EID: 54249130794     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.08-0763     Document Type: Article

References (29)

1. Barnes PJ. Pathophysiology of asthma. Eur Respir J 2003; 23:84-113
2. Global Initiative for Asthma. Global strategy for asthma management and prevention, 2007. Available at: www.ginasthma.com/. Accessed July 28, 2008
3. Jatakanon A, Sim L, Kharitonov SA, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53:91-95
4. Strunk RC, Szefler SJ, Phillips B, et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. Am Acad Allergy Asthma Immunol 2003; 112:883-892
5. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6:1368-1370
6. Crater SE, Peters EJ, Martin ML, et al. Expired nitric oxide and airway obstruction in asthma patients with an acute exacerbation. Am J Respir Crit Care Med 1999; 159:806-811
7. Kharitonov SA, Yates DH, Barnes PJ. Inhaled antileukotrienes decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996; 153:454-457
8. Massaro AF, Gaston B, Kita D, et al. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995; 152:800-803
9. Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47:25-29
10. Pizzichini MM, Pizzichini E, Clelland L, et al. Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J 1999; 13:15-21
11. Jatakanon A, Lim S, Chung KF, et al. An inhaled steroid improves markers of airway inflammation in patients with mild asthma. Eur Respir J 1998; 12:1084-1088
12. Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352:2163-2173
13. Pijnenburg MW, Bakker EM, Hop WC, et al. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005; 172:831-836
14. Shaw DE, Berry MA, Thomas M, et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 2007; 176; 231-237
15. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360:1715-1721
16. Jayaram L, Pizzichini MM, Cook RJ, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006; 27:483-494
17. Chlumsky J, Striz I, Terl M, et al. Strategy aimed at reduction of sputum eosinophils decreases exacerbation rate in patients with asthma. J Int Med Res 2006; 34:129-139
18. Petsky HL, Kynaston JA, Turner C, et al. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2007; 2:CD005603
19. Juniper EF, Bousquet J, Abetz L, et al. Identifying "well controlled" and "not well-controlled" asthma using the Asthma Control Questionnaire. Respir Med 2005; 100:616-621
20. Clausen JL, Coates AL, Quanjer PH. Measurement of lung volumes in humans: review and recommendations from an ATS/ERS workshop. Eur Respir J 1997; 10:1205-1206
21. American Thoracic Society. Guidelines for methacholine and exercise challenge testing. Am J Respir Crit Care Med 1999; 161:309-329
22. ATS/ERS recommendations for standardized procedures for online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171:912-930
23. Olivieri M, Talamini G, Corradi M, et al. Reference values for exhaled nitric oxide (REVENO) study. Respir Res 2006; 7:94-99
24. Malerba M, Ricciardolo F, Radaeli A, et al. Neutrophilic inflammation and IL-8 levels in induced sputum of α-1-antitrypsin PiMZ subjects. Thorax 2006; 61:129-133
25. Balbi B, Pignatti P, Corradi M, et al. Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults. Eur Respir J 2007; 30:769-781
26. Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001; 164:738-743
27. Montuschi P, Mondino C, Koch P, et al. Effects of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in children with asthma. Chest 2007; 132:1876-1881
28. Piacentini GL, Bodini A, Costella S, et al. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children. Eur Respir J 1999; 13:1386-1390
29. Taylor DR, Town GI, Herbison GP, et al. Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol. Thorax 1998; 53:744-752